In this episode, host Alyssa Watson, DVM, talks with Diane Delmain, DVM, DABVP, about her recent Clinician’s Brief article, “Remdesivir & GS-441524 for Treatment of FIP.” Dr. Delmain discusses the relationship between the two drugs, the hurdles veterinarians face in prescribing them, and the FDA’s stance on compounded GS-441524. She also covers the limitations of retrospective data and the risks associated with unregulated products. Plus, Dr. Delmain shares advice for monitoring for adverse effects and long-term care for cats recovering from FIP.Resources:https://www.cliniciansbrief.com/article/remdesivir-gs441524-feline-infectious-peritonitis-treatmenthttps://www.simparicatriodvm.comContact:[email protected] To Find Us:Website: CliniciansBrief.com/PodcastsYouTube: Youtube.com/@clinicians_briefFacebook: Facebook.com/CliniciansBriefLinkedIn: LinkedIn.com/showcase/CliniciansBrief/Instagram: @Clinicians.BriefX: @CliniciansBriefThe Team:Alyssa Watson, DVM - HostAlexis Ussery - Producer & Multimedia Specialist

Ver todos los episodios